DE60004191D1 - Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung - Google Patents

Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung

Info

Publication number
DE60004191D1
DE60004191D1 DE60004191T DE60004191T DE60004191D1 DE 60004191 D1 DE60004191 D1 DE 60004191D1 DE 60004191 T DE60004191 T DE 60004191T DE 60004191 T DE60004191 T DE 60004191T DE 60004191 D1 DE60004191 D1 DE 60004191D1
Authority
DE
Germany
Prior art keywords
polyethylene glycol
active substance
pharmaceutical composition
solubilizer
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60004191T
Other languages
English (en)
Other versions
DE60004191T2 (de
Inventor
Johannes Didriksen
Leth Gerlach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Publication of DE60004191D1 publication Critical patent/DE60004191D1/de
Application granted granted Critical
Publication of DE60004191T2 publication Critical patent/DE60004191T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60004191T 1999-04-13 2000-04-05 Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung Expired - Lifetime DE60004191T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900486 1999-04-13
DK48699 1999-04-13
PCT/EP2000/003022 WO2000061112A2 (en) 1999-04-13 2000-04-05 Solubilized pharmaceutical composition for parenteral administration

Publications (2)

Publication Number Publication Date
DE60004191D1 true DE60004191D1 (de) 2003-09-04
DE60004191T2 DE60004191T2 (de) 2004-04-22

Family

ID=8094111

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60004191T Expired - Lifetime DE60004191T2 (de) 1999-04-13 2000-04-05 Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung

Country Status (16)

Country Link
EP (1) EP1171100B1 (de)
JP (1) JP2003511348A (de)
KR (1) KR20010111585A (de)
CN (1) CN1226999C (de)
AT (1) ATE245968T1 (de)
AU (1) AU768785B2 (de)
CA (1) CA2369587C (de)
DE (1) DE60004191T2 (de)
DK (1) DK1171100T3 (de)
ES (1) ES2206225T3 (de)
HK (1) HK1049789B (de)
HU (1) HUP0203903A3 (de)
PL (1) PL356968A1 (de)
PT (1) PT1171100E (de)
RU (1) RU2001130462A (de)
WO (1) WO2000061112A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2368824T3 (es) 1998-03-27 2011-11-22 Oregon Health & Science University Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
GB0513984D0 (en) * 2005-07-07 2005-08-17 Teva Pharma Dosage form
WO2009100176A2 (en) * 2008-02-07 2009-08-13 Abbott Laboratories Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
NZ591261A (en) * 2008-09-12 2012-12-21 Critical Pharmaceuticals Ltd Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
US9233100B2 (en) * 2012-02-06 2016-01-12 Merial, Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
EP2749266B1 (de) * 2012-12-27 2018-08-29 Pharmathen S.A. Stabile injizierbare pharmazeutische Zusammensetzung eines Vitamin-D-Rezeptoragonisten und Prozess zur Herstellung davon
AR100873A1 (es) * 2014-06-17 2016-11-09 Clariant Produkte Deutschland Gmbh Proceso para el desgomado de composiciones que contienen triglicéridos
KR101983654B1 (ko) * 2018-07-24 2019-05-29 한국과학기술원 Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물
MX2021005950A (es) * 2018-11-26 2021-07-06 Orphanix Gmbh Formulaciones pediatricas acuosas de retinol.
CN115177586A (zh) * 2022-08-31 2022-10-14 江苏知原药业股份有限公司 一种卡泊三醇组合物
CN115350151B (zh) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 一种高稳定性阿法骨化醇液体口服制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1062389B (de) * 1958-02-11 1959-07-30 Wander Ag Dr A Verfahren zur Herstellung von sterilen, Kalziumsalze enthaltenden Vitamin-D-Loesungen
GB1123433A (en) * 1964-09-28 1968-08-14 Eastman Kodak Co Intramuscularly injectable vitamin a preparation
WO1996036340A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION
DE19609477A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile wäßrige Solubilisate von Carotinoiden und Vitamine
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs

Also Published As

Publication number Publication date
AU4293900A (en) 2000-11-14
JP2003511348A (ja) 2003-03-25
WO2000061112A2 (en) 2000-10-19
EP1171100B1 (de) 2003-07-30
HUP0203903A2 (hu) 2003-03-28
ATE245968T1 (de) 2003-08-15
RU2001130462A (ru) 2003-06-20
CN1226999C (zh) 2005-11-16
CN1382036A (zh) 2002-11-27
WO2000061112A3 (en) 2002-09-26
DK1171100T3 (da) 2003-11-24
CA2369587C (en) 2009-12-22
PT1171100E (pt) 2003-11-28
HUP0203903A3 (en) 2004-09-28
CA2369587A1 (en) 2000-10-19
HK1049789A1 (en) 2003-05-30
ES2206225T3 (es) 2004-05-16
EP1171100A1 (de) 2002-01-16
PL356968A1 (en) 2004-07-12
DE60004191T2 (de) 2004-04-22
KR20010111585A (ko) 2001-12-19
AU768785B2 (en) 2004-01-08
HK1049789B (zh) 2006-02-24

Similar Documents

Publication Publication Date Title
DE60004191D1 (de) Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung
ATE207346T1 (de) Orale pharmazeutische zusammensetzungen mit sexualhormonen
HRP20030765B1 (en) Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability
ES2193658T3 (es) Procedimiento para la preparacion de formulaciones acuosas para uso oftalmico.
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
BR0314916A (pt) Espuma farmacêutica e cosmética
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
PE20020225A1 (es) Composiciones farmaceuticas de farmacos poco solubles
CY1106064T1 (el) Τυποποιηση ενος εστερα τεστοστepονης για ανθρωπινη χρηση
TNSN04023A1 (fr) Formulation de suspension orale stabilisee
EE05072B1 (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
HUP0302452A2 (hu) Prosztaglandin E1-et tartalmazó topikus gyógyászati készítmények
MY101536A (en) Anti-inflammatory and analgesic tape for external use
PE20040499A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
DE50211435D1 (de) Verfahren zur Herstellung eines Wirkstoffkonzentrats sowie Wirkstoffkonzentrat
BR9912275A (pt) Formulação de bioimplante
BR9913135A (pt) Formulação oral
BRPI0418115A (pt) formulação lìquida estável de hormÈnio de crescimento
BR0215303A (pt) Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
AR041826A1 (es) Formulaciones de liberacion prolongada en formas de suspension
BR0007666A (pt) Composição cosmética com base em mentol e mentil lactato, tendo pouco odor e sendo não irritante
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition